Journal of Clinical Oncology - ASCO Pub - Abstract - Pancreatic Cancer and other GI Tumors harboring a KRAS (G12C) Mutation. Alex Spria, MD, PhD, FACP

Virginia Cancer Specialists Practice Blog

January 20, 2022
Virginia Cancer Specialists » VCS Practice News » Physicians » VCS Practice News » Alex Spira MD PhD FACP » Journal of Clinical Oncology – ASCO Pub – Abstract – Pancreatic Cancer and other GI Tumors harboring a KRAS (G12C) Mutation. Alex Spria, MD, PhD, FACP

KRYSTAL-1: Updated activity and safety of adagrasib (MRTX849) in patients (Pts) with unresectable or metastatic pancreatic cancer (PDAC) and other gastrointestinal (GI) tumors harboring a KRASG12C mutation.

, , , , , , , , , , , , , Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ; US Oncology Research/Virginia Cancer Specialists, Fairfax, VA; Memorial Sloan Kettering Cancer Center, New York, NY; Southern California Permenente Medical Group, Los Angeles, CA; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Sarah Cannon Research Institute, Nashville, TN; Texas Oncology, Dallas, TX; Yale University School of Medicine, New Haven, CT; Mirati Therapeutics, Inc., San Diego, CA; Janssen Research and Development, LLC, San Diego, CA; Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI

Learn More here: https://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.519?utm_medium=cpc&utm_campaign=J_Clin_Oncol_TrendMD_0&utm_source=TrendMD#.Yei3b8vXpqs.twitter

Award Winning Physicians

Our Physicians work for you, ensuring the highest standard of care.

Learn More